We recently published a list of 20 Best Stock To Buy According to Marjorie Taylor Greene. In this article, we are going to ...

Over the past five years, the stock has recorded a negative one-day return in 65% of cases, with a median decline of -2.4% ...

Momentum stocks are nursing a hangover, and value investing is finally crashing the afterparty. Prem Watsa, the Canadian ...

We recently compiled a list of Billionaire Prem Watsa’s 10 Stock Picks With Highest Potential. In this article, we are going ...

a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license agreement with United States-based Merck, ...

Now, a new logo has been unveiled to indicate that a bottle is in full compliance with the rules—and yes, it’s still voluntary, but it’s also another step in the right direction. The ...

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s patent cliff at bay. In a push to keep the Keytruda gravy train on the ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...

Data on federal individual contributions downloaded from the Federal Election Commission on 02/06/2025. State and local contributions are uploaded on a rolling basis. Federal law prohibits the use of ...

a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license agreement with United States-based Merck ...